AllianceBernstein’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.6M | Sell |
141,486
-1,562,725
| -92% | -$50.8M | ﹤0.01% | 1512 |
|
|
2025
Q1 | $64.4M | Sell |
1,704,211
-75,151
| -4% | -$2.84M | 0.02% | 513 |
|
|
2024
Q4 | $146M | Buy |
1,779,362
+133,448
| +8% | +$10.9M | 0.05% | 288 |
|
|
2024
Q3 | $188M | Sell |
1,645,914
-88,907
| -5% | -$10.2M | 0.06% | 236 |
|
|
2024
Q2 | $131M | Sell |
1,734,821
-45,882
| -3% | -$3.46M | 0.05% | 307 |
|
|
2024
Q1 | $122M | Sell |
1,780,703
-134,344
| -7% | -$9.18M | 0.04% | 359 |
|
|
2023
Q4 | $120M | Sell |
1,915,047
-28,783
| -1% | -$1.81M | 0.05% | 348 |
|
|
2023
Q3 | $99.1M | Buy |
1,943,830
+55,724
| +3% | +$2.84M | 0.04% | 380 |
|
|
2023
Q2 | $94.3M | Buy |
1,888,106
+1,804,718
| +2,164% | +$90.1M | 0.04% | 405 |
|
|
2023
Q1 | $3.13M | Buy |
83,388
+9,700
| +13% | +$364K | ﹤0.01% | 1623 |
|
|
2022
Q4 | $3.53M | Buy |
73,688
+28,488
| +63% | +$1.37M | ﹤0.01% | 1590 |
|
|
2022
Q3 | $1.09M | Hold |
45,200
| – | – | ﹤0.01% | 2237 |
|
|
2022
Q2 | $984K | Buy |
45,200
+1,200
| +3% | +$26.1K | ﹤0.01% | 2348 |
|
|
2022
Q1 | $1.06M | Buy |
44,000
+6,900
| +19% | +$167K | ﹤0.01% | 2400 |
|
|
2021
Q4 | $883K | Hold |
37,100
| – | – | ﹤0.01% | 2506 |
|
|
2021
Q3 | $941K | Buy |
37,100
+6,900
| +23% | +$175K | ﹤0.01% | 2507 |
|
|
2021
Q2 | $680K | Buy |
30,200
+7,800
| +35% | +$176K | ﹤0.01% | 2676 |
|
|
2021
Q1 | $442K | Sell |
22,400
-4,000
| -15% | -$78.9K | ﹤0.01% | 2702 |
|
|
2020
Q4 | $701K | Hold |
26,400
| – | – | ﹤0.01% | 2431 |
|
|
2020
Q3 | $1.3M | Buy |
+26,400
| New | +$1.3M | ﹤0.01% | 2059 |
|